Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06314529 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Long-term Follow-up Study of BHC001 for TDT

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor Study First Submitted
161 trials monitored
See 6 trials at risk
Observe long-term safety risk and long-term efficacy after intravenous infusion of BHC001 in TDT subjects.
Trial Details
NCT Number NCT06314529
Lead Sponsor Bioray Laboratories
Collaborators: The 923rd Hospital of Joint Logistics Support Force of People's Liberation Army, Xiangya Hospital of Central South University
Conditions
(from sponsor)
Thalassemia, Beta
Related terms beta-Thalassemia
Enrollment 6 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov